Evogene Ltd. plans to list on the Nasdaq Global Market.
The company will delist from the New York Stock Exchange and start trading on Nasdaq on Dec. 30. under the EVGN symbol.
Evogene to list on Nasdaq Global Market
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises